Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans

Anesthesiology

Volumn 106, Issue 5, 2007, Pages 1013-1018

  Martin, Frédéric ^a,b   Fletcher, Dominique ^a,c   Chauvin, Marcel ^a   Bouhassira, Didier ^a,b  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PARECOXIB; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; FEMALE; FLEXOR REFLEX; HUMAN; HUMAN EXPERIMENT; MALE; NEUROMODULATION; NOCICEPTIVE STIMULATION; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SURAL NERVE; VOLUNTEER;

ADULT; CROSS-OVER STUDIES; CYCLOOXYGENASE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISOXAZOLES; MALE; PAIN; PAIN THRESHOLD; REFLEX; SPINAL CORD;

EID: 34247568933     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000265162.39932.33     Document Type: Article

References (39)

1. Vane JR: Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231:232-5
2. Burian M, Geisslinger G: COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005; 107:139-54
3. Ito S, Okuda-Ashitaka E, Minami T: Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 2001; 41:299-332
4. Simmons DL, Botting RM, Hla T: Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition. Pharmacol Rev 2004; 56:387-437
5. Stichtenoth DO, Frolich JC: The second generation of COX-2 inhibitors: What advantages do the newest offer? Drugs 2003; 63:33-45
6. Warner TD, Mitchell JA: Cyclooxygenases: New forms, new inhibitors, and lessons from the clinic. FASEB J 2004; 18:790-804
7. Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam MA, Baron JA, Investigators tAPPoVAT: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005; 352:1092-102
8. Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M, the Adenoma Prevention with Celecoxib (APC) Study Investigators: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352:1071-80
9. Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005; 352:1081-91
10. McCormack K, Brune K: Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs: A survey of their analgesic efficacy. Drugs 1991; 41:533-47
11. Breder CD, Dewitt D, Kraig RP: Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995; 355:296-315
12. Beiche F, Scheuerer S, Brune K, Geisslinger G, Goppelt-Struebe M: Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett 1996; 390:165-9
13. Vanegas H, Schaible HG: Prostaglandins and cyclooxygenases in the spinal cord. Prog Neurobiol 2001; 64:327-63
14. Koppert W, Wehrfritz A, Korber N, Sittl R, Albrecht S, Schuttler JMS: The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain 2004; 108:148-53
15. Sycha T, Anzenhofer S, Lehr S, Schmetterer L, Chizh B, Eichler HG, Gustorff B: Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: A randomized, double blinded, placebo controlled crossover trial in the UV-B pain model. Pain 2005; 113:316-22
16. Burns D, Hill L, Essandoh M, Jarzembowski TM, Schuler HG, Janicki PK: Effect of valdecoxib pretreatment on pain and secondary hyperalgesia: A randomized controlled trial in healthy volunteers. BMC Anesthesiol 2006; 10:6-3
17. Barden J, Edwards JE, McQuay HJ, Moore RA: Oral valdecoxib and injected parecoxib for acute postoperative pain: A quantitative systematic review. BMC Anesthesiol 2003; 3:1-8
18. Willer JC: Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 1977; 3:69-80
19. Skljarevski V, Ramadan NM: The nociceptive flexion reflex in humans: Review article. Pain 2002; 96:3-8
20. Sandrini G, Serrao M, Rossi P, Romaniello A, Cruccu G, Willer JC: The lower limb flexion reflex in humans. Prog Neurobiol 2005; 77:353-95
21. Willer JC, Harrewyn JM: Central inhibitory effect of intravenous ketoprofen on the nociceptive flexion reflex in man. Presse Med 1987; 16:63-7
22. Sandrini G, Ruiz L, Capararo M, Garofoli F, Beretta AGN: Central analgesic activity of ibuprofen: A neurophysiological study in humans. Int J Clin Pharmacol Res 1992; 12:197-204
23. Guieu R, Blin O, Pouget J, Serratrice G: Analgesic effect of indomethacin shown using the nociceptive flexion reflex in humans. Ann Rheum Dis 1992; 51:391-3
24. Herrero JF, Laird JM, Lopez-Garcia JA: Wind-up of spinal cord neurones and pain sensation: Much ado about something? Prog Neurobiol 2000; 61:169-203
25. Guirimand F, Dupont X, Brasseur L, Chauvin M, Bouhassira D: The effects of ketamine on the temporal summation "wind-up" of the nociceptive flexion (RIII) reflex and pain in humans. Anesth Analg 2000; 90:408-14
26. Bossard AE, Guirimand F, Fletcher D, Gaude-Joindreau V, Chauvin M, Bouhassira D: Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain 2002; 98:47-57
27. Karim A, Laurent A, Slater ME, Kuss ME, Qian J, Crosby-Sessoms SL, Hubbard RC: A pharmacokinetic study of intramuscular (i.m.) parecoxib sodium in normal subjects. J Clin Pharmacol 2001; 41:1111-9
28. Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC: The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. J Am Dent Assoc 2004; 135:1578-90
29. Ferreira SH, Lorenzetti BB, Correa FM: Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol 1978; 53:39-48
30. Zhu X, Conklin D, Eisenach JC: Cyclooxygenase-1 in the spinal cord plays an important role in postoperative pain. Pain 2003; 104:15-23
31. Samad TA, Sapirstein A, Woolf CJ: Prostanoids and pain: Unraveling mechanisms and revealing therapeutic targets. Trends Mol Med 2002; 8:390-6
32. Martin TJ, Buechler NL, Eisenach JC: Intrathecal administration of a cylcooxygenase-1, but not a cyclooxygenase-2 inhibitor, reverses the effects of laparotomy on exploratory activity in rats. Anesth Analg 2006; 103:690-5
33. Willer JC, De Broucker T, Bussel B, Roby-Brami A, Harrewyn JM: Central analgesic effect of ketoprofen in humans: Electrophysiological evidence for a supraspinal mechanism in a double-blind and cross-over study. Pain 1989; 38:1-7
34. Ma W, Du W, Eisenach JC: Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res 2002; 937:94-9
35. Malmberg AB, Yaksh TL: Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992; 257:1276-9
36. Li J, Simone DA, Larson AA: Wind-up leads to characteristics of central sensitization. Pain 1999; 79:75-82
37. Chapman V, Dickenson AH: The spinal and peripheral roles of bradykinin and prostaglandins in nociceptive processing in the rats. Eur J Pharmacol 1992; 219:427-33
38. Laird JMA, Herrero JF, Garcia de la Rubia P: Analgesic activity of the novel COX-2 preferring NSAID, meloxicam in mono-arthritics rats: Central and peripheral components. Inflamm Res 1997; 46:203-10
39. Willingale HL, Gardiner NJ, McLymont N, Giblett S, Grubb BD: Prostanoids synthesized by cyclo-oxygenase isoforms in rat spinal cord and their contribution to the development of neuronal hyperexcitability. Br J Pharmacol 1997; 122:1593-604